Search research articles
Contact Us
Filters
Showing results (341-350 of 426) with videos related to
Page
of 43
Sort By:
The American Journal of Tropical Medicine and Hygiene
|
May 2, 2018
Case Report: Hemianopia: From Suspected Glioblastoma to the Diagnosis of Ectopic Schistosomiasis Haematobium Infection in a Traveler Returning from the Republic of the Congo
Séverine Loridant, Gabriel Mouahid, Marjorie Cornu, et al.
Neurology
|
September 11, 2015
A geographical cluster of progressive supranuclear palsy in northern France
Dominique Caparros-Lefebvre, Lawrence I Golbe, Vincent Deramecourt, et al.
Biomarkers in Medicine
|
May 19, 2010
Tau as a biomarker of neurodegenerative diseases
Susanna Schraen-Maschke, Nicolas Sergeant, Claire-Marie Dhaenens, et al.
Journal of Alzheimer'S Disease : JAD
|
August 17, 2013
Juvenile frontotemporal dementia with parkinsonism associated with tau mutation G389R
Marie-Pierre Chaunu, Vincent Deramecourt, Valérie Buée-Scherrer, et al.
Cells
|
December 23, 2022
Quantitative Targeted Absolute Proteomics for Better Characterization of an In Vitro Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells
Marie-Pierre Dehouck, Masanori Tachikawa, Yutaro Hoshi, et al.
Journal of Neuro-Oncology
|
October 4, 2005
Increasing of HER2 membranar density in human glioblastoma U251MG cell line established in a new nude mice model
Jean-François Mineo, Anne Bordron, Isabelle Quintin-Roué, et al.
Brain Pathology (Zurich, Switzerland)
|
July 27, 2019
Identification of prognostic markers in diffuse midline gliomas H3K27M-mutant
Charlotte Dufour, Romain Perbet, Pierre Leblond, et al.
Acta Neuropathologica Communications
|
January 29, 2014
Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer's disease
Johnatan Ceccom, Najat Loukh, Valérie Lauwers-Cances, et al.
Alzheimer'S Research & Therapy
|
October 7, 2025
Anti-tau VHH therapy against PHF6: a safe approach to slowing the phenotype of tau pathology
Raphaelle Caillierez, Clémence Leboullenger, Sarah Leclercq, et al.
Cancers
|
June 28, 2023
A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas
Julia Gilhodes, Adèle Meola, Bastien Cabarrou, et al.
Page
of 43
Search research articles
Search
Showing results (341-350 of 426) with videos related to
Sort By:
Page
of 43
The American Journal of Tropical Medicine and Hygiene
|
May 2, 2018
Case Report: Hemianopia: From Suspected Glioblastoma to the Diagnosis of Ectopic Schistosomiasis Haematobium Infection in a Traveler Returning from the Republic of the Congo
Séverine Loridant, Gabriel Mouahid, Marjorie Cornu, et al.
Neurology
|
September 11, 2015
A geographical cluster of progressive supranuclear palsy in northern France
Dominique Caparros-Lefebvre, Lawrence I Golbe, Vincent Deramecourt, et al.
Biomarkers in Medicine
|
May 19, 2010
Tau as a biomarker of neurodegenerative diseases
Susanna Schraen-Maschke, Nicolas Sergeant, Claire-Marie Dhaenens, et al.
Journal of Alzheimer'S Disease : JAD
|
August 17, 2013
Juvenile frontotemporal dementia with parkinsonism associated with tau mutation G389R
Marie-Pierre Chaunu, Vincent Deramecourt, Valérie Buée-Scherrer, et al.
Cells
|
December 23, 2022
Quantitative Targeted Absolute Proteomics for Better Characterization of an In Vitro Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells
Marie-Pierre Dehouck, Masanori Tachikawa, Yutaro Hoshi, et al.
Journal of Neuro-Oncology
|
October 4, 2005
Increasing of HER2 membranar density in human glioblastoma U251MG cell line established in a new nude mice model
Jean-François Mineo, Anne Bordron, Isabelle Quintin-Roué, et al.
Brain Pathology (Zurich, Switzerland)
|
July 27, 2019
Identification of prognostic markers in diffuse midline gliomas H3K27M-mutant
Charlotte Dufour, Romain Perbet, Pierre Leblond, et al.
Acta Neuropathologica Communications
|
January 29, 2014
Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer's disease
Johnatan Ceccom, Najat Loukh, Valérie Lauwers-Cances, et al.
Alzheimer'S Research & Therapy
|
October 7, 2025
Anti-tau VHH therapy against PHF6: a safe approach to slowing the phenotype of tau pathology
Raphaelle Caillierez, Clémence Leboullenger, Sarah Leclercq, et al.
Cancers
|
June 28, 2023
A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas
Julia Gilhodes, Adèle Meola, Bastien Cabarrou, et al.
Page
of 43